Related Experiment Video
Updated: Feb 2, 2026
05:39
Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus
Published on: May 16, 2025
663
Pediatric lupus nephritis
Sergio Veloso Brant Pinheiro1, Raphael Figuiredo Dias1, Rafaela Cabral Gonçalves Fabiano1
1Universidade Federal de Minas Gerais, Hospital das Clínicas, Unidade de Nefrologia Pediátrica, Belo Horizonte, MG, Brasil.
Jornal Brasileiro De Nefrologia
|November 23, 2018
Summary
Lupus nephritis (LN) severely affects kidneys in systemic lupus erythematosus (SLE), particularly in children. This review details pediatric LN, covering its causes, symptoms, kidney damage, and treatments.
Area of Science:
- Nephrology
- Pediatric Rheumatology
- Immunology
Background:
- Lupus nephritis (LN) is a severe manifestation of systemic lupus erythematosus (SLE).
- Pediatric patients experience more frequent and severe LN, leading to higher morbidity and mortality.
- Understanding pediatric LN is crucial for improving patient outcomes.
Purpose of the Study:
- To provide a comprehensive overview of lupus nephritis in children and adolescents.
- To focus on the unique aspects of pediatric LN, including its etiopathogenesis and clinical presentation.
- To review current knowledge on renal tissue alterations and treatment strategies for pediatric LN.
Main Methods:
- This study is a narrative review.
- Literature search on lupus nephritis in pediatric populations.
- Synthesis of information on disease mechanisms, clinical features, pathology, and therapeutics.
Main Results:
- LN presents unique challenges in pediatric SLE patients.
- Etiopathogenesis, clinical manifestations, and renal pathology in children differ from adults.
- Current treatment options aim to manage disease activity and preserve renal function.
Conclusions:
- Pediatric lupus nephritis requires specialized attention due to its severity and impact on long-term health.
- Further research into pediatric-specific treatments and management strategies is warranted.
- Early diagnosis and tailored interventions are key to improving prognosis in young LN patients.
Related Concept Videos
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
261
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
261
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
307
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
307
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
227
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
227
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
298
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
298